Home LiteratureArticle Details
PMID: 21088132 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Lymphomas differ in their dependence on Epstein-Barr virus.

Blood ·Vol. 117 ·No. 6 ·2011-02-10 ·Pages 1977-85

Vereide DT, Sugden B

Abstract

Epstein-Barr virus (EBV) encodes oncogenic information and, oftentimes concomitant with host immunosuppression, gives rise to malignancies in all major categories of lymphoma defined by the World Health Organization. Here, we conditionally evicted the viral extrachromosomal genome from tumor cells in vitro to examine the role of EBV in different lymphomas, including Burkitt lymphoma (BL) and posttransplant lymphoproliferative disorder. Cells derived from 2 canonical BLs were found to have the least dependence on the virus; some required EBV to prevent the inefficient induction of apoptosis. In contrast, cells derived from a subset of BL, Wp-restricted BL, required EBV to block a robust apoptotic program that involves the up-regulation of the proapoptotic protein Bim. Wp-restricted BL cells also relied on the virus to promote efficient proliferation, a distinction that highlights the multiple contributions EBV makes to affect proliferation of its host cells. Like Wp-BL cells, posttransplant lymphoproliferative disorder cells depended on the virus to inhibit apoptosis. They furthermore required the virus to drive them out of G(1)/G(0). Together, these results reveal a graded dependence on EBV among tumor cells that directly correlates with the number of viral genes expressed in the tumor cell.

MeSH Terms
Apoptosis/genetics Apoptosis Regulatory Proteins/genetics Bcl-2-Like Protein 11 Burkitt Lymphoma/genetics,pathology,virology Cell Line, Tumor Cell Proliferation Epstein-Barr Virus Infections/genetics,pathology,virology Genes, myc Genome, Viral Herpesvirus 4, Human/genetics,pathogenicity Humans Lymphoma/genetics,pathology,virology Lymphoproliferative Disorders/etiology,genetics,pathology,virology Membrane Proteins/genetics Models, Biological Oncogenes Proto-Oncogene Proteins/genetics Transplants/adverse effects
Chemicals
Apoptosis Regulatory Proteins BCL2L11 protein, human Bcl-2-Like Protein 11 Membrane Proteins Proto-Oncogene Proteins
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Vereide David T
McArdle Laboratory for Cancer Research, University of Wisconsin, Madison, WI 53706, USA.
Sugden Bill
References (48)
48 references, click to expand
  1. The coupling of synthesis and partitioning of EBV's plasmid replicon is revealed in live cells.
    EMBO J. 2007 Oct 3;26(19):4252-62 PMID: 17853891
  2. Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma.
    Lancet. 2003 Jan 18;361(9353):217-23 PMID: 12547545
  3. Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma.
    Blood. 1995 Jul 15;86(2):659-65 PMID: 7605996
  4. The LMP1 oncogene of EBV activates PERK and the unfolded protein response to drive its own synthesis.
    Blood. 2008 Feb 15;111(4):2280-9 PMID: 18042799
  5. Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2.
    Nat Med. 2002 Oct;8(10):1098-104 PMID: 12219084
  6. Burkitt lymphoma: revisiting the pathogenesis of a virus-associated malignancy.
    Hematology Am Soc Hematol Educ Program. 2007;:277-84 PMID: 18024641
  7. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function.
    Mol Cell. 2005 Feb 4;17(3):393-403 PMID: 15694340
  8. Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion.
    Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3260-5 PMID: 10737792
  9. Lack of sustained regression of c-MYC-induced mammary adenocarcinomas following brief or prolonged MYC inactivation.
    Cancer Cell. 2004 Dec;6(6):577-86 PMID: 15607962
  10. Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients.
    Blood. 2010 Feb 4;115(5):925-35 PMID: 19880495
  11. Epstein-Barr Virus DNA recombination and loss in sporadic Burkitt's lymphoma.
    J Infect Dis. 1996 Mar;173(3):529-35 PMID: 8627013
  12. Posttransplantation lymphoproliferative disorders.
    Arch Intern Med. 2003 Sep 22;163(17):1997-2004 PMID: 14504111
  13. Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes.
    J Virol. 1994 May;68(5):3410-4 PMID: 8151802
  14. Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27.
    EMBO J. 1999 Oct 1;18(19):5321-33 PMID: 10508165
  15. Action of Myc in vivo - proliferation and apoptosis.
    Curr Opin Genet Dev. 2000 Feb;10(1):100-5 PMID: 10679391
  16. Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen.
    Science. 1996 Sep 6;273(5280):1384-6 PMID: 8703072
  17. The ornithine decarboxylase gene is a transcriptional target of c-Myc.
    Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7804-8 PMID: 8356088
  18. Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma.
    Oncogene. 2008 Jan 17;27(4):421-33 PMID: 17653091
  19. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell.
    Immunity. 2000 Oct;13(4):497-506 PMID: 11070168
  20. Epstein-Barr virus provides a survival factor to Burkitt's lymphomas.
    Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14269-74 PMID: 14603034
  21. Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV.
    J Virol. 1994 Sep;68(9):6069-73 PMID: 8057484
  22. The Epstein-Barr virus Bcl-2 homolog, BHRF1, blocks apoptosis by binding to a limited amount of Bim.
    Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5663-8 PMID: 19293378
  23. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice.
    Science. 1995 Mar 10;267(5203):1506-10 PMID: 7878471
  24. The microRNAs of Epstein-Barr Virus are expressed at dramatically differing levels among cell lines.
    Virology. 2009 Apr 10;386(2):387-97 PMID: 19217135
  25. Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor.
    EMBO J. 1998 Mar 16;17(6):1700-9 PMID: 9501091
  26. The plasmid replicon of Epstein-Barr virus: mechanistic insights into efficient, licensed, extrachromosomal replication in human cells.
    Plasmid. 2007 Jul;58(1):1-12 PMID: 17350094
  27. Dominant-negative inhibitors of EBNA-1 of Epstein-Barr virus.
    J Virol. 1997 Mar;71(3):1766-75 PMID: 9032305
  28. Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: molecular analysis of primary tumor tissue.
    Blood. 1998 Feb 15;91(4):1373-81 PMID: 9454768
  29. The affinity of EBNA1 for its origin of DNA synthesis is a determinant of the origin's replicative efficiency.
    J Virol. 2008 Jun;82(12):5693-702 PMID: 18385243
  30. Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes.
    Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14188-93 PMID: 16966603
  31. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.
    Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12616-21 PMID: 9356498
  32. B-cell proliferation and induction of early G1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2.
    EMBO J. 1995 Jan 3;14(1):88-96 PMID: 7828599
  33. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells.
    Proc Natl Acad Sci U S A. 1982 Dec;79(24):7837-41 PMID: 6818551
  34. Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing.
    Immunity. 1997 Dec;7(6):791-802 PMID: 9430224
  35. Classification of lymphoid neoplasms: the microscope as a tool for disease discovery.
    Blood. 2008 Dec 1;112(12):4384-99 PMID: 19029456
  36. Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell.
    J Virol. 1997 Jul;71(7):4882-91 PMID: 9188550
  37. Programmed cell death: alive and well in the new millennium.
    Trends Cell Biol. 2001 Dec;11(12):526-34 PMID: 11719060
  38. Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis.
    J Virol. 2005 Aug;79(16):10709-17 PMID: 16051863
  39. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state.
    J Virol. 1994 Nov;68(11):7374-85 PMID: 7933121
  40. Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2r gamma(null) humanized mice.
    Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13022-7 PMID: 20615947
  41. Mechanisms of tamoxifen resistance.
    Endocr Relat Cancer. 2004 Dec;11(4):643-58 PMID: 15613444
  42. Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy.
    Leukemia. 2002 Nov;16(11):2190-6 PMID: 12399961
  43. Transfer of a functional human immune system to mice with severe combined immunodeficiency.
    Nature. 1988 Sep 15;335(6187):256-9 PMID: 2970594
  44. An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link.
    PLoS Pathog. 2009 Mar;5(3):e1000341 PMID: 19283066
  45. Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions.
    Oncogene. 2007 Feb 26;26(9):1297-305 PMID: 17322915
  46. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells.
    EMBO J. 1987 Sep;6(9):2743-51 PMID: 2824192
  47. Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex.
    Oncogene. 1996 Feb 1;12(3):621-9 PMID: 8637719
  48. Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival.
    EMBO J. 1996 Dec 16;15(24):7070-8 PMID: 9003782
Article Info
Journal
Blood
Abbr.
Blood
ISSN
1528-0020
Published
2011-02-10
Epub
2010-00-18
Pages
1977-85
Language
English
Region
United States
NLM ID
7603509
PMCID
PMC3056644
Subset
IM
Grants
NCI NIH HHS · P01 CA022443 · United States
NCI NIH HHS · R01 CA070723 · United States
NCI NIH HHS · R01 CA133027 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com